0041 GMT - Investors appear to like the strategic pivot by Ramsay Health Care's new CEO Natalie Davis. Ramsay's share price leaps 15% to its highest level in nearly three months after the company said it is reviewing its majority stake in European private hospital business Ramsay Santé. News of the review comes just days after Ramsay said it has paused investment in expanding its Elysium mental health services business in the U.K. as it concentrates on improving performance. "Board clearly positioning for break-up scenarios, admitting Elysium and Santé have not worked," says Wilsons analyst Shane Storey. Assessing Ramsay's 1H result, Wilsons says activity levels appears to have held up well. (david.winning@wsj.com; @dwinningWSJ)
(END) Dow Jones Newswires
February 26, 2025 19:41 ET (00:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.